Skip to main content
. 2017 Mar 6;13(2):175–180. doi: 10.3988/jcn.2017.13.2.175

Table 3. Sensitivity, specificity, and accuracy of the in-house CBA.

Assay Definite NMOSD Sensitivity (95% CI) Accuracy (95% CI) High risk NMOSD Sensitivity (95% CI) Accuracy (95% CI) OND Specificity (95% CI)
Tested + Tested + Tested +
In-house CBA 178 142 80 (73.1–85.4) 80 (73.1–85.4) 63 48 76 (63.8–86.0) 76 (63.8–86.0) 145 0 100 (97.5–100)

CBA: cell based assay, CI: confidence interval, NMOSD: neuromyelitis optica spectrum disorder, OND: other neurological diseases.